# FDA recall D-1516-2014

> **Novartis Pharmaceuticals Corp.** · Class III · drug recall initiated 2014-07-30.

## Product

Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey  07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.

## Reason for recall

Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1516-2014
- **Recalling firm:** Novartis Pharmaceuticals Corp.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-07-30
- **Report date:** 2014-08-13
- **Termination date:** 2014-12-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Suffern, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1516-2014

## Citation

> AI Analytics. FDA recall D-1516-2014. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1516-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*